Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of Spheroid Forming Capacity and TRAIL Sensitivity by KLF4 and Nanog in Gastric Cancer Cells. | Curr Issues Mol Biol | 2022 | 36661504 | PubTator, text mining | PubMed |
| Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces. | Cancer Drug Resist | 2022 | 36627897 | PubTator, text mining | PubMed |
| Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2022 | 36614089 | PubTator, text mining | PubMed |
| Apoptosis as a Barrier against CIN and Aneuploidy. | Cancers (Basel) | 2022 | 36612027 | PubTator, text mining | PubMed |
| Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM. | NPJ Precis Oncol | 2022 | 36575299 | PubTator, text mining | PubMed |
| Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections. | Front Immunol | 2022 | 36569952 | PubTator, text mining | PubMed |
| Antisense oligonucleotide is a promising intervention for liver diseases. | Front Pharmacol | 2022 | 36569303 | PubTator, text mining | PubMed |
| Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer. | Genes (Basel) | 2022 | 36553449 | PubTator, text mining | PubMed |
| Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations. | Am J Cancer Res | 2022 | 36504908 | PubTator, text mining | PubMed |
| Yamogenin-Induced Cell Cycle Arrest, Oxidative Stress, and Apoptosis in Human Ovarian Cancer Cell Line. | Molecules | 2022 | 36500274 | PubTator, text mining | PubMed |
| Comprehensive Evaluation of University Safety Culture Construction Level Based on "2-4" Model. | Int J Environ Res Public Health | 2022 | 36498218 | PubTator, text mining | PubMed |
| Short Linear Motifs in Colorectal Cancer Interactome and Tumorigenesis. | Cells | 2022 | 36496998 | PubTator, text mining | PubMed |
| Monosaccharide Composition and In Vitro Activity to HCT-116 Cells of Purslane Polysaccharides after a Covalent Chemical Selenylation. | Foods | 2022 | 36496556 | PubTator, text mining | PubMed |
| Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies. | Clin Exp Vaccine Res | 2022 | 36451664 | PubTator, text mining | PubMed |
| Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review. | Int J Mol Sci | 2022 | 36430164 | PubTator, text mining | PubMed |
| Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene. | Diagnostics (Basel) | 2022 | 36428851 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. | Medicina (Kaunas) | 2022 | 36422202 | PubTator, text mining | PubMed |
| Distribution, Function, and Expression of the Apelinergic System in the Healthy and Diseased Mammalian Brain. | Genes (Basel) | 2022 | 36421846 | PubTator, text mining | PubMed |
| Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction. | Elife | 2022 | 36409067 | PubTator, text mining | PubMed |
| Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies. | Front Nutr | 2022 | 36386899 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=14